Kodiak Gas Services just delivered the sort of earnings beat that forces short sellers to rethink their thesis.
The stock jumped nearly 8% on May 11 after first-quarter results, capping a month that now shows a 24% gain from the start of April to Monday's close of $75.14. KGS has outrun every close peer over that stretch — closest correlate AROC fell 6.5% on the week, while FLOC and NGS each posted smaller gains than KGS in the same period. Compression services, it seems, is finding favour while broader oilfield services wavers.
The short book has been in full retreat since the print. Short interest in KGS dropped 15% over the past week to roughly 6.1% of the free float — down from a peak above 7% in late April. The move suggests active cover rather than passive drift; shorts built through most of April and then got caught wrong-footed by the Q1 beat. Borrow conditions reinforce that message. The cost to borrow collapsed to just 0.21% annualised, less than half its level a week ago and well below the 0.55% seen in early May. Availability is extremely wide, with the lending pool barely under strain at roughly 3% utilisation against a 52-week peak of nearly 30%. New shorts face no friction whatsoever in accessing stock to borrow, which means the recent cover was driven by conviction, not a squeeze.
Options positioning has pivoted sharply toward the bullish side. The put/call ratio has dropped to 0.81, nearly 0.8 standard deviations below its 20-day average of 1.05. That is a meaningful swing: through most of April the PCR was running close to 2.0, reflecting heavy defensive hedging into earnings. The unwinding of that hedge after the beat is the clearest signal that the crowd's bias has flipped. With the 52-week low PCR at 0.05, there is still room for calls to build further, but the direction of travel is unambiguous.
The Street is in catch-up mode on price targets. Citigroup lifted its target from $63 to $86 yesterday — with the stock at $75, that implies roughly 15% upside from current levels and puts Citi firmly at the bullish end of coverage. Goldman Sachs raised to $69 in late April (now below current price). Across the board, analysts have been ratcheting targets higher all year: RBC, Barclays, and Goldman have each made multiple upward revisions since January, and not one firm has cut its rating. The consensus mean sits at $73, which — after Monday's close — is fractionally below the current price, suggesting the Street is already behind the tape and further target lifts are likely to follow. The EV/EBITDA multiple of 10.3x has compressed modestly over the past month as earnings grew into the valuation, and the forward earnings yield of 3.6% is modest but not stretched for an infrastructure-adjacent compressor business.
Institutional holders have been building steadily. BlackRock added 2.5 million shares to hold 13.7% of the company, while Invesco added more than a million to reach 9.5%. Vanguard and Fidelity also increased. The breadth of the institutional accumulation — across passive and active managers alike — reflects a stock moving from small-cap obscurity into index relevance. Insider activity from March was mixed: the Chairman bought 6,000 shares at $54.81, while several C-suite executives sold into the strength, likely driven by equity award monetisation. The net insider picture over the 90-day period shows a modest positive balance.
The ORTEX short score has eased to 41.5 and is trending lower all week, consistent with the cover cycle. With no next earnings date yet in the calendar, the watch points become the pace of further analyst target revisions — and whether the gap between Citi's $86 and the current consensus of $73 closes upward or the stock pulls back to meet the average.
See the live data behind this article on ORTEX.
Open KGS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
